327 related articles for article (PubMed ID: 6594194)
21. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
22. Specific uptake of 1,25-dihydroxycholecalciferol by human chronic myeloid leukemia cells.
Freake HC; Iwasaki J; McCarthy DM
Cancer Res; 1984 Aug; 44(8):3627-31. PubMed ID: 6331655
[TBL] [Abstract][Full Text] [Related]
23. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.
Abe J; Moriya Y; Saito M; Sugawara Y; Suda T; Nishii Y
Cancer Res; 1986 Dec; 46(12 Pt 1):6316-21. PubMed ID: 3490908
[TBL] [Abstract][Full Text] [Related]
24. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.
Munker R; Norman A; Koeffler HP
J Clin Invest; 1986 Aug; 78(2):424-30. PubMed ID: 3461004
[TBL] [Abstract][Full Text] [Related]
26. 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters.
Bettens F; Schlick E; Farrar W; Ruscetti F
J Cell Physiol; 1986 Dec; 129(3):295-302. PubMed ID: 3491083
[TBL] [Abstract][Full Text] [Related]
27. The involvement of calcium ions in the effect of 1,25-dihydroxyvitamin D3 on HL-60 cells.
Levy R; Nathan I; Barnea E; Chaimovitz C; Shany S
Exp Hematol; 1988 May; 16(4):290-4. PubMed ID: 3129299
[TBL] [Abstract][Full Text] [Related]
28. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
29. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
30. Similarity and dissimilarity between phorbol ester tumor promoters and 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3.
Kuroki T; Suda T
Princess Takamatsu Symp; 1983; 14():89-99. PubMed ID: 6394594
[TBL] [Abstract][Full Text] [Related]
31. 1,25-Dihydroxyvitamin D3 activates secretion of hydrogen peroxide by human monocytes.
Cohen MS; Mesler DE; Snipes RG; Gray TK
J Immunol; 1986 Feb; 136(3):1049-53. PubMed ID: 3079794
[TBL] [Abstract][Full Text] [Related]
32. Preferential growth inhibition of human leukemic versus normal myeloid colony-forming cells by 12-O-tetradecanoylphorbol-13-acetate.
Park CH
Exp Hematol; 1984 Jun; 12(5):285-90. PubMed ID: 6723821
[TBL] [Abstract][Full Text] [Related]
33. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
34. Regulation of TNF-alpha release from bone marrow-derived macrophages by vitamin D.
Abu-Amer Y; Bar-Shavit Z
J Cell Biochem; 1994 Aug; 55(4):435-44. PubMed ID: 7962175
[TBL] [Abstract][Full Text] [Related]
35. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
36. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
[TBL] [Abstract][Full Text] [Related]
37. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
38. Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1.
Pelus LM; Broxmeyer HE; Clarkson BD; Moore MA
Cancer Res; 1980 Jul; 40(7):2512-5. PubMed ID: 6930324
[TBL] [Abstract][Full Text] [Related]
39. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
Kawagoe H; Potter M; Ellis J; Grosveld GC
Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
[TBL] [Abstract][Full Text] [Related]
40. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
